Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
15 May 24
SC 13G
Travere Therapeutics, Inc.
1 May 24
SC 13G/A
Xilio Therapeutics, Inc.
5 Apr 24
SC 13G
Xilio Therapeutics, Inc.
14 Feb 24
SC 13G/A
Tempest Therapeutics, Inc.
14 Feb 24
SC 13G/A
SPRUCE BIOSCIENCES, INC.
14 Feb 24
SC 13G/A
Mereo BioPharma Group plc
14 Feb 24
SC 13G/A
Mereo BioPharma Group plc
14 Feb 24
SC 13G/A
Inozyme Pharma, Inc.
14 Feb 24
SC 13G/A
Immunocore Holdings plc
14 Feb 24
SC 13G/A
Gamida Cell Ltd.
14 Feb 24
SC 13G/A
Spyre Therapeutics, Inc.
14 Feb 24
SC 13G/A
AGIOS PHARMACEUTICALS, INC.
14 Feb 24
SC 13G/A
Aclaris Therapeutics, Inc.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
SC 13G/A
Sierra Oncology, Inc.
14 Feb 23
SC 13G/A
PhaseBio Pharmaceuticals Inc
14 Feb 23
SC 13G/A
Mirum Pharmaceuticals, Inc.
14 Feb 23
SC 13G/A
Compass Therapeutics, Inc.
14 Feb 23
SC 13G/A
Tempest Therapeutics, Inc.
14 Feb 23
SC 13G/A
SPRUCE BIOSCIENCES, INC.
14 Feb 23
SC 13G/A
Mereo Biopharma Group plc
14 Feb 23
SC 13G/A
Inozyme Pharma, Inc.
14 Feb 23
SC 13G/A
Immunocore Holdings plc
14 Feb 23
SC 13G
Aeglea BioTherapeutics, Inc.
14 Feb 23
SC 13G
AGIOS PHARMACEUTICALS, INC.
14 Feb 23
SC 13G/A
Aclaris Therapeutics, Inc.
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 22
13F-HR
Quarterly holdings report by institutional manager
15 Aug 22
13F-HR
Quarterly holdings report by institutional manager
16 May 22
SC 13G
Inozyme Pharma, Inc.
25 Apr 22
SC 13G
Mereo Biopharma Group plc
15 Feb 22
SC 13G/A
ARDELYX, INC.
15 Feb 22
SC 13G/A
SPRUCE BIOSCIENCES, INC.
15 Feb 22
SC 13G/A
Immunocore Holdings plc
15 Feb 22
SC 13G/A
Mirum Pharmaceuticals, Inc.
15 Feb 22